Literature DB >> 22989165

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus.

Anuradhani Kasturiratne1, Sanjaya Weerasinghe, Anuradha S Dassanayake, Shaman Rajindrajith, Arjuna P de Silva, Norihiro Kato, A Rajitha Wickremasinghe, H Janaka de Silva.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is linked to metabolic syndrome, and is known to be associated with impaired fasting glycemia and diabetes mellitus. This prospective community-based study was conducted to determine the association between NAFLD and incidence of diabetes mellitus in an urban adult population in Sri Lanka.
METHODS: Participants of the Ragama Health Study cohort were assessed for NAFLD using established ultrasound criteria in 2007. Those who were free of diabetes at baseline were followed up for 3 years. Incidence rates of diabetes mellitus were compared between subjects with and without NAFLD at baseline.
RESULTS: Out of 2984 subjects, 926 had NAFLD and 676 had diabetes in 2007. Of the 2276 subjects who were free of diabetes in 2007, 1914 were re-assessed in 2010. After 3 years, 104 out of 528 subjects with NAFLD and 138 out of 1314 subjects without NAFLD had developed diabetes mellitus de novo. Incidence rates of diabetes were respectively 64.2 and 34 per 1000 person-years of follow up for those with and without NAFLD. NAFLD was an independent predictor of developing diabetes mellitus. Other independent predictors were impaired fasting glycemia and dyslipidemia.
CONCLUSIONS: Subjects with ultrasonically diagnosed NAFLD have an increased risk of developing diabetes mellitus. Intervention for NAFLD through lifestyle modification may prevent progression of the current diabetes epidemic.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 22989165     DOI: 10.1111/j.1440-1746.2012.07264.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  28 in total

Review 1.  Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment.

Authors:  Nathalie C Leite; Cristiane A Villela-Nogueira; Claudia R L Cardoso; Gil F Salles
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Multiorgan, Multimodality Imaging in Cardiometabolic Disease.

Authors:  Vidhya Kumar; Willa A Hsueh; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

3.  Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.

Authors:  Arun J Sanyal; Scott L Friedman; Arthur J McCullough; Lara Dimick-Santos
Journal:  Hepatology       Date:  2015-03-19       Impact factor: 17.425

4.  A multicentric prospective study evaluating the safety and efficacy of Kii® Fios® First Entry Trocar in laparoscopic bariatric surgery.

Authors:  Marcelo Loureiro; Mohamad Ramadan; El Mehdi Skalli; Pierre Blanc; Jean Michel Fabre; David Nocca
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

Review 5.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

6.  Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.

Authors:  Wei-Dong Li; Kun-Fa Fu; Gui-Mei Li; Yan-Shu Lian; Ai-Min Ren; Yun-Jue Chen; Jin-Rong Xia
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

7.  Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries.

Authors:  Ke-Qing Shi; Fa-Ling Wu; Wen-Yue Liu; Chen-Chen Zhao; Chang-Xi Chen; Yao-Yao Xie; Sheng-Jie Wu; Xian-Feng Lin; Yong-Ping Chen; Danny Ka-Ho Wong; Man-Fung Yuen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

Review 8.  Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Authors:  Liang Liu; Ping Li; Yiqi Liu; Yilian Zhang
Journal:  Dig Dis Sci       Date:  2019-06-15       Impact factor: 3.199

9.  Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA).

Authors:  Luis A Rodriguez; Alka M Kanaya; Stephen C Shiboski; Alicia Fernandez; David Herrington; Jingzhong Ding; Patrick T Bradshaw
Journal:  Ann Epidemiol       Date:  2021-07-19       Impact factor: 3.797

10.  Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese.

Authors:  Xiaoming Li; Mingfeng Xia; Hui Ma; Yu Hu; Hongmei Yan; Wanyuan He; Huandong Lin; Naiqing Zhao; Jian Gao; Xin Gao
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.